Mylan responded to backlash over the price of its EpiPen by promising to reduce the costs that some patients pay, though stopped short of saying it would cut prices.
WSJ.com: What's News US, Wall Street Journal
Thu, 08/25/2016 - 5:11am
Mylan responded to backlash over the price of its EpiPen by promising to reduce the costs that some patients pay, though stopped short of saying it would cut prices.